Cargando…
The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy
Lung cancer is the most common cancer worldwide. Disappointingly, despite great effort in encouraging screening or, at least, a close surveillance of high-risk individuals, most of lung cancers are diagnosed when already surgically unresectable because of local advancement or metastasis. In these ca...
Autores principales: | Visconti, Roberta, Morra, Francesco, Guggino, Gianluca, Celetti, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535867/ https://www.ncbi.nlm.nih.gov/pubmed/28653990 http://dx.doi.org/10.3390/ijms18071374 |
Ejemplares similares
-
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
por: Criscuolo, Daniela, et al.
Publicado: (2022) -
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
por: Criscuolo, Daniela, et al.
Publicado: (2019) -
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer
por: Cerrato, Aniello, et al.
Publicado: (2018) -
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
por: Morra, Francesco, et al.
Publicado: (2015) -
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
por: Morra, Francesco, et al.
Publicado: (2019)